In addition, this study confirms that RUFY3 can promote the growth, invasion and metastasis of HCC cell by activating NF-κB-induced EMT, which may provide a potential target for the treatment of HCC. The gene discussed is NFKB1; the disease is hepatocellular carcinoma.